Intel Investing Cash Flow increased by 147.1% to $3.09B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3718.5%, from $81.00M to $3.09B. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -11.6% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$6.91B | -$10.63B | -$4.74B | -$2.64B | $220.00M | -$4.57B | -$3.24B | -$8.52B | -$2.81B | -$7.39B | -$5.32B | -$2.56B | -$9.17B | -$2.76B | -$3.76B | $81.00M | -$2.09B | -$6.25B | -$6.57B | $3.09B |
| QoQ Change | — | -53.8% | +55.4% | +44.3% | +108.3% | <-999% | +29.1% | -162.9% | +67.0% | -163.3% | +28.1% | +51.8% | -257.6% | +69.8% | -36.2% | +102.2% | <-999% | -199.6% | -5.1% | +147.1% |
| YoY Change | — | — | — | — | +103.2% | +57.0% | +31.6% | -222.9% | <-999% | -61.8% | -64.1% | +69.9% | -226.4% | +62.6% | +29.2% | +103.2% | +77.2% | -126.1% | -74.4% | >999% |